Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 147 JPY -0.6% Market Closed
Market Cap: 32.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Daito Pharmaceutical Co Ltd stock under the Base Case scenario is 2 433.41 JPY. Compared to the current market price of 2 147 JPY, Daito Pharmaceutical Co Ltd is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 433.41 JPY
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Daito Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Daito Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Daito Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Daito Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Daito Pharmaceutical Co Ltd.

What unique competitive advantages
does Daito Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Daito Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Daito Pharmaceutical Co Ltd.

Provide P/S
for Daito Pharmaceutical Co Ltd.

Provide P/E
for Daito Pharmaceutical Co Ltd.

Provide P/OCF
for Daito Pharmaceutical Co Ltd.

Provide P/FCFE
for Daito Pharmaceutical Co Ltd.

Provide P/B
for Daito Pharmaceutical Co Ltd.

Provide EV/S
for Daito Pharmaceutical Co Ltd.

Provide EV/GP
for Daito Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Daito Pharmaceutical Co Ltd.

Provide EV/EBIT
for Daito Pharmaceutical Co Ltd.

Provide EV/OCF
for Daito Pharmaceutical Co Ltd.

Provide EV/FCFF
for Daito Pharmaceutical Co Ltd.

Provide EV/IC
for Daito Pharmaceutical Co Ltd.

Show me price targets
for Daito Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Daito Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Daito Pharmaceutical Co Ltd?

What are the Net Income projections
for Daito Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Daito Pharmaceutical Co Ltd?

What are the EPS projections
for Daito Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Daito Pharmaceutical Co Ltd?

What are the EBIT projections
for Daito Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Daito Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Daito Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Daito Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Daito Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Daito Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Daito Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Daito Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Daito Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Daito Pharmaceutical Co Ltd.

Provide ROE
for Daito Pharmaceutical Co Ltd.

Provide ROA
for Daito Pharmaceutical Co Ltd.

Provide ROIC
for Daito Pharmaceutical Co Ltd.

Provide ROCE
for Daito Pharmaceutical Co Ltd.

Provide Gross Margin
for Daito Pharmaceutical Co Ltd.

Provide Operating Margin
for Daito Pharmaceutical Co Ltd.

Provide Net Margin
for Daito Pharmaceutical Co Ltd.

Provide FCF Margin
for Daito Pharmaceutical Co Ltd.

Show all solvency ratios
for Daito Pharmaceutical Co Ltd.

Provide D/E Ratio
for Daito Pharmaceutical Co Ltd.

Provide D/A Ratio
for Daito Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Daito Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Daito Pharmaceutical Co Ltd.

Provide Quick Ratio
for Daito Pharmaceutical Co Ltd.

Provide Current Ratio
for Daito Pharmaceutical Co Ltd.

Provide Cash Ratio
for Daito Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Daito Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Daito Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Daito Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Daito Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Daito Pharmaceutical Co Ltd

Current Assets 45.8B
Cash & Short-Term Investments 4.7B
Receivables 18.6B
Other Current Assets 22.5B
Non-Current Assets 36.1B
Long-Term Investments 2.3B
PP&E 31.4B
Intangibles 492m
Other Non-Current Assets 1.9B
Current Liabilities 18.8B
Accounts Payable 11B
Other Current Liabilities 7.8B
Non-Current Liabilities 11.1B
Long-Term Debt 8.8B
Other Non-Current Liabilities 2.3B
Efficiency

Earnings Waterfall
Daito Pharmaceutical Co Ltd

Revenue
47.4B JPY
Cost of Revenue
-37.8B JPY
Gross Profit
9.6B JPY
Operating Expenses
-6B JPY
Operating Income
3.7B JPY
Other Expenses
-433m JPY
Net Income
3.2B JPY

Free Cash Flow Analysis
Daito Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Daito Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive Operating Income
Positive 1-Year Revenue Growth
47/100
Profitability
Score

Daito Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Daito Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
74/100
Solvency
Score

Daito Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Daito Pharmaceutical Co Ltd

Wall Street analysts forecast Daito Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Daito Pharmaceutical Co Ltd is 2 835.6 JPY with a low forecast of 2 807.8 JPY and a high forecast of 2 919 JPY.

Lowest
Price Target
2 807.8 JPY
31% Upside
Average
Price Target
2 835.6 JPY
32% Upside
Highest
Price Target
2 919 JPY
36% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Daito Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Daito Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

32.8B JPY

Dividend Yield

2.79%

Description

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Contact

TOYAMA-KEN
Toyama-shi
326, Yoka-machi
+81764215665.0
www.daitonet.co.jp

IPO

2010-03-24

Employees

846

Officers

Director
Masuo Nomura
Exe.Off., GM of Quality Assurance Depart. & Deputy Head of Quality & Regulatory Affairs Divi.
Yoji Nakamura
Exec. Off., Deputy Head of Production Division and GM of Production Planning & Management Dept.
Yoshinori Nakajima
Executive Officer and Head of Research & Development Division
Eiichi Takata
Exec. Offi., Deputy Head of Production Divis. & GM of API Produ. Depart. and API Technical Offi.
Masahiko Mouri
Executive Officer, Head of Purchasing & Logistics Div. and GM of Osaka Branch & Int. Business Dept.
Norio Kishi

See Also

Discover More
What is the Intrinsic Value of one Daito Pharmaceutical Co Ltd stock?

The intrinsic value of one Daito Pharmaceutical Co Ltd stock under the Base Case scenario is 2 433.41 JPY.

Is Daito Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 147 JPY, Daito Pharmaceutical Co Ltd is Undervalued by 12%.

Back to Top